HA

Himani Agarwal

Active Director Director DIN 11079347
DIN 11079347 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Himani Agarwal

Data last updated:

Himani Agarwal is a Director at Amrutya Pharma Private Limited (since 2025) and Director at Diew Pharma Private Limited (since 2025).

DIN 11079347
Primary Designation Director
First Appointment 28 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amrutya Pharma Private Limited U47721RJ2025PTC104244
Director05 Jul 20252025Active
Diew Pharma Private Limited U21002RJ2025PTC102280
Director28 Apr 20252025Active

Board colleagues of Himani Agarwal

Directorship timeline

Open interactive timeline →
Amrutya Pharma Private Limited
Diew Pharma Private Limited
Premium access

Shareholding and investment profile for Himani Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Himani Agarwal

Himani Agarwal currently holds 2 directorships: Amrutya Pharma Private Limited (Director, since 05 Jul 2025); Diew Pharma Private Limited (Director, since 28 Apr 2025).

Himani Agarwal was first appointed on 28 Apr 2025 as Director at Diew Pharma Private Limited.

The current boards of Himani Agarwal's companies include Akash Goenka (Amrutya Pharma Private Limited), Praveen Budakia (Amrutya Pharma Private Limited), Jaspreet Bhardwaj (Diew Pharma Private Limited), Suman Kanwar (Diew Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available